Item 5. Market for Registrant’s Common Equity
ITEM 5.
MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Our common stock is traded on the Nasdaq Global Select Market (“Nasdaq”) under the symbol “CBRL.” There were 6,615 shareholders of record as of September 13, 2023.
See Note 4 to Consolidated Financial Statements with respect to dividend restrictions. See Dividends, Share Repurchases and Share-Based Compensation Awards under Part II, Item 7 Management’s
Discussion and Analysis of Financial Condition, Liquidity and Capital Resources for further information regarding our dividends.
See the table labeled “Equity Compensation Plan Information” to be contained in the 2023 Proxy Statement, incorporated by reference in Part III, Item 12 of this Annual Report on Form 10-K.
Part III, Item 12 of this Annual Report on Form 10-K is incorporated herein by this reference.
Unregistered Sales of Equity Securities
There were no equity securities sold by the Company during the period covered by this Annual Report on Form 10-K that were not registered under the Securities Act of 1933, as
amended.
Issuer Purchases of Equity Securities
We did not repurchase any shares of our common stock in the fourth quarter ended July 28, 2023. On June 2, 2022, our Board of
Directors approved the repurchase of up to $200,000 of our common stock with such authorization to expire on June 2, 2023. On June 2, 2023, our Board of Directors extended this repurchase authorization for an additional year.
ITEM 6.
RESERVED
30
Table of Contents
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.